BioSig Technologies Inc - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BSGM Nasdaq 3845 https://biosigtech.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioSig Technologies Inc

Infectious Diseases Expert Prof. Angus Dalgleish Joins ViralClear’s Scientific Advisory Board - Aug 6th, 2020 2:00 pm
ViralClear Appoints Dr. Michael Sofia to Its Scientific Advisory Board - Aug 5th, 2020 6:09 pm
LD Micro - Announces Preliminary List of Presenters for the LD-500. - Aug 5th, 2020 3:15 pm
BioSig Installs PURE EP(tm) System at Massachusetts General Hospital - Aug 4th, 2020 1:25 pm
BioSig Awarded CAGE Code by the Systems for Award Management (SAM) - Aug 3rd, 2020 6:00 pm
BioSig Technologies to Present at the Proactive Investors One2One Virtual Event on August 4, 2020 - Jul 30th, 2020 5:00 pm
BioSig Technologies to Participate in LD Micro’s Zooming with LD - Jul 23rd, 2020 12:30 pm
ViralClear Announces Formation of Its Scientific Advisory Board - Jul 20th, 2020 5:50 pm
BioSig Technologies to Participate in the B Riley FBR Virtual Infectious Disease Summit - Jul 17th, 2020 6:42 pm
'Zooming with LD' to Feature 10 Distinct Companies July 20th-31st - Jul 16th, 2020 3:00 pm
BioSig Technologies, Inc. Adopts Stockholder Rights Agreement - Jul 16th, 2020 2:30 pm
Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial Sites - Jul 13th, 2020 5:42 pm
BioSig Submits Application to Systems for Award Management (SAM) with U.S. Government - Jul 10th, 2020 5:15 pm
BioSig Technologies Inc. Appoints Tony Zook to the Board of Directors - Jul 1st, 2020 1:15 pm
BioSig Technologies, Inc Closes $17.5 Million Common Stock Offering - Jun 29th, 2020 12:18 pm
BioSig Technologies, Inc. Announces $17.5 Million Common Stock Only Registered Direct Offering - Jun 24th, 2020 1:20 pm
ViralClear Partners with Catalent on Potential Treatment for COVID-19 - Jun 22nd, 2020 6:30 pm
ViralClear Opens Enrollment with First Patient Dosing in Phase II Human Trial of Anti-Viral MMPD Oral Solution for Treatment of COVID-19 - Jun 17th, 2020 11:55 am
Reminder - BioSig Subsidiary, ViralClear to Host Conference Call on June 9th to Discuss Upcoming and Recent Developments for Phase II Human Clinical Trials of its Broad-Spectrum Oral Anti-Viral Candidate for Treatment of COVID-19 - Jun 8th, 2020 7:02 pm
ViralClear adds St. David's HealthCare in Austin, Texas, to its Planned Phase II trial for its Broad-Spectrum Oral Anti-Viral Candidate for COVID-19 - Jun 5th, 2020 1:10 pm